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Cl−/HCO−3 exchangers are expressed abundantly in cardiac muscle, suggesting that HCO
−
3
extrusion serves an important function in heart. Mice lacking Anion Exchanger Isoform
3 (AE3), a major cardiac Cl−/HCO−3 exchanger, appear healthy, but loss of AE3 causes
decompensation in a hypertrophic cardiomyopathy (HCM) model. Using intra-ventricular
pressure analysis, in vivo pacing, and molecular studies we identified physiological and
biochemical changes caused by loss of AE3 that may contribute to decompensation
in HCM. AE3-null mice had normal cardiac contractility under basal conditions and
after β-adrenergic stimulation, but pacing of hearts revealed that frequency-dependent
inotropy was blunted, suggesting that AE3-mediated HCO−3 extrusion is required for
a robust force-frequency response (FFR) during acute biomechanical stress in vivo.
Modest changes in expression of proteins that affect Ca2+-handling were observed,
but Ca2+-transient analysis of AE3-null myocytes showed normal twitch-amplitude and
Ca2+-clearance. Phosphorylation and expression of several proteins implicated in HCM
and FFR, including phospholamban (PLN), myosin binding protein C, and troponin I were
not altered in hearts of paced AE3-null mice; however, phosphorylation of Akt, which plays
a central role in mechanosensory signaling, was significantly higher in paced AE3-null
hearts than in wild-type controls and phosphorylation of AMPK, which is affected by Akt
and is involved in energy metabolism and some cases of HCM, was reduced. These data
show loss of AE3 leads to impaired rate-dependent inotropy, appears to affect mechanical
stress-responsive signaling, and reduces activation of AMPK, which may contribute to
decompensation in heart failure.
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INTRODUCTION
Despite the abundance of Cl−/HCO−3 exchangers in heart, which
include the AE1, AE2, and AE3 anion exchangers (Slc4a1–3)
and putative anion transporter 1 (PAT1; Slc26a6) (Kudrycki
et al., 1990; Knauf et al., 2001; Wang et al., 2002; Alvarez et al.,
2004), their role in regulating cardiac function remains poorly
understood. In epithelial tissues, Cl−/HCO−3 exchangers, func-
tioning coordinately with Na+-loading mechanisms, facilitate
pH-neutral Na+ and Cl− ion fluxes (Melvin et al., 2005; Alper,
2009; Gawenis et al., 2010), thereby contributing to anion secre-
tion and volume regulation. In erythrocytes on the other hand,
AE1 plays a key structural role in maintaining the cytoskeletal
stability of erythrocyte membranes (Peters et al., 1996; Southgate
et al., 1996) in addition to being involved in gas exchange (Bruce
et al., 2003; Jensen, 2004). Anion Exchanger Isoform 3 (AE3),
which has a cardiac-specific variant (Linn et al., 1992) and is
most highly expressed in heart (Kudrycki et al., 1990), has been
localized to both t-tubules and sarcolemma, with apparent foci
of expression at costameres (Alvarez et al., 2007a), which are
complexes involved in mechanical stress sensing and mechan-
otransduction (Samarel, 2005). However, an essential role for AE3
in heart is not self-evident as AE3-null mice appear healthy and
exhibit normal cardiac performance under basal conditions and
after β-adrenergic stimulation (Prasad et al., 2008).
The first direct evidence that AE3 plays an important role in
heart was the finding that the additional loss of AE3 in NKCC1
Na+-K+-2Cl− cotransporter-null mice led to impaired contrac-
tility (Meyer et al., 2002; Prasad et al., 2008). More recently, loss
of AE3 was shown to dramatically increase the rate of decom-
pensation in a transgenic mouse α-tropomyosin Glu180Gly
(TM180) hypertrophic cardiomyopathy (HCM)model. Although
the degree of hypertrophy and expression of markers of hypertro-
phy were not increased, loss of AE3 led to reduced contractility
and relaxation and a sharply reduced life-span (Al Moamen et al.,
2011). These findings showed that loss of AE3 expression and
activity, although benign under normal circumstances, leads to
changes that contribute to decompensation in HCM and eventual
heart failure.
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To identify changes that might contribute to the predisposi-
tion to heart failure we analyzed AE3-null mice on an FVB/N
background, which was used in our previous studies of the inter-
actions of AE3 ablation and TM180-induced HCM (Al Moamen
et al., 2011). Cardiovascular performance of AE3-null mice on
the FVB/N background was normal under both basal conditions
and in response to β-adrenergic stimulation, as seen previously
in mice on a mixed 129Svj and Black Swiss background (Prasad
et al., 2008). However, when heart rates were increased by pacing
in vivo, a procedure that subjects the heart to acute biomechanical
stress, the positive force-frequency relationship/response (FFR)
was blunted, a common occurrence in heart failure (Rossman
et al., 2004). To better understand the role of AE3 in heart disease
and rate-dependent inotropy, we also analyzed, under both basal
conditions and after in vivo pacing at elevated heart rates, a num-
ber of phosphorylated proteins that have been implicated in heart
disease and that function under conditions of varying biome-
chanical stress. Consistent with an altered response to biome-
chanical stress, phosphorylation of Akt was increased in AE3-null
hearts when subjected to elevated heart rates but not at basal heart
rates. In contrast, phosphorylation of AMPK, which serves as a
master regulator of energy metabolism (Zaha and Young, 2012)
and is affected by Akt activation, was reduced during pacing.
These results show that AE3 ablation impacts inotropic responses
and signaling mechanisms elicited by acute biomechanical stress
in vivo and suggest that AE3-mediated Cl−/HCO−3 exchange plays
an important protective role in conditions leading to HCM.
MATERIALS AND METHODS
GENERATION OF MUTANT MICE
Generation and genotype analysis of AE3-null mice has been
described previously (Prasad et al., 2008). Mice used in this study
were on an inbred FVB/N background. All procedures conformed
to guidelines published by the National Institutes of Health
(Guide for the Care and Use of Laboratory Animals; Publication
No. 86-23, revised 1996) and were approved by the Institutional
Animal Care and Use Committee at the University of Cincinnati.
ANALYSIS OF In vivo CARDIOVASCULAR PERFORMANCE AND
FORCE-FREQUENCY RELATIONSHIPS
Analysis of cardiovascular function was performed as described
previously (Lorenz and Robbins, 1997; Periasamy et al., 1999).
Intraventricular pressure (IVP) measurements in the left ventricle
of mice anesthetized with ketamine and inactin (50 and 100μg/g
bodyweight) were carried out using aMillar high-fidelity pressure
transducer inserted via the right carotid artery. The right femoral
artery was cannulated with a fluid-filled catheter connected to
a pressure transducer for blood pressure measurements. Drugs
were infused via the right femoral vein. Anesthetized mice were
subjected to closed-chest atrial pacing as described previously
(D’Angelo et al., 1997; Al Moamen et al., 2011). Heart rates were
electrically paced, with increments of 50 beats per minute (bpm),
and cardiovascular parameters were recorded as described above.
REAL-TIME PCR ANALYSIS
Total RNA was isolated from wild-type and AE3-null hearts
as previously described (Al Moamen et al., 2011) and cDNA
generated using oligo dT primers and the Superscript III First-
strand system (Invitrogen; 18080-051). Real-time PCR (RT-PCR)
analysis of cDNA was carried out using the Absolute Blue
qPCR SYBR mix (Thermo Scientific; AB4219/B), the Opticon2
DNA Engine (MJ Research Inc.), and QuantiTect primer assays
(Qiagen) targeted against mRNA for the following genes: Slc4a4
encoding NBCe1 (Primer assay: QT01053675), Slc4a7 encoding
NBCn1 (Primer assay: QT01037036), and Slc26a6 encoding
PAT1 (Primer assay: QT01661828). Expression of individual
genes was normalized to expression levels of Gapdh, which
were determined as previously described (Al Moamen et al.,
2011). Results were analyzed using the Opticon Monitor Analysis
Software (Ver. 3.1).
ANALYSIS OF Ca2+ TRANSIENTS
Ventricular myocytes were isolated from adult mouse hearts as
described previously (O’Connell et al., 2003) using an enzyme
mixture of Liberase Blendzyme IV (Roche) at 0.25mg/mL and
trypsin (Invitrogen) at 0.14mg/mL. Cells were loaded with
Fura2-AM (Molecular Probes Inc.; Eugene, OR) at a final
concentration of 2μM for 15–20min at room temperature and
fluorescence measurements were made using a dual-beam spec-
trofluorophotometer (PTI International, Birmingham, NJ) after
field stimulation at 0.5Hz (Ji et al., 2006). Data were acquired
using Felix 3.01 acquisition software (PTI International) and
tracings of Ca2+ transients were obtained by calculating fluores-
cence ratios (340:380 nm). Ionoptix Ionwizard Analysis Software
(IonOptix LLC, Milton, MA) was used for analysis.
IMMUNOBLOT ANALYSIS
Hearts were harvested from anesthetized mice (15μl of 2.5%
Avertin/g bodyweight) and total homogenates prepared as
described previously (Prasad et al., 2008). For analyses of phos-
phorylated proteins in instrumented control and paced hearts
(550 bpm), left ventricular tissue was collected from mice that
were surgically instrumented as described above. Hearts were
paced from baseline to 550 bpm, with increments of 50 bpm.
After recording of parameters, the chest-cavity was opened as
pacing at 550 bpm was continued, and ventricular tissue at the
apex of the heart was rapidly excised and immediately frozen
in liquid N2 prior to preparation of total heart homogenates.
Protein concentrations were estimated using a modified Bradford
assay (Thermo Scientific). Proteins were resolved on reduc-
ing SDS polyacrylamide gels, transferred to nitrocellulose or
PVDF membranes and incubated with specific primary anti-
bodies followed by corresponding secondary antibodies (KPL,
Gaithersburg MD, USA). Protein bands were visualized using
the KPL LumiGlo chemiluminescent substrate system (KPL,
Gaithersburg MD, USA). The primary antibodies for SERCA2a,
phospholamban (PLN), phospho-Ser16 and phospho-Thr17 of
PLN, the NCX1 Na+/Ca2+ exchanger, the L-type Ca2+ channel
α2 subunit, the cardiac ryanodine receptor (RyR2), and sarcom-
eric actin (as a loading control) were the same as used previ-
ously (Prasad et al., 2008; Al Moamen et al., 2011). Additional
antibodies used were those for the NHE1 Na+/H+ exchanger
(MAB3140, clone 4E9: Millipore); MyBP-C (sc-67353: Santa
Cruz Biotechnology); phospho-Ser282 myosin binding protein-C
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(MyBP-C) (ALX-215, Alexis Biochemicals); total and phospho-
Ser22/23 cardiac troponin I (TnI) (4002 and 4004, respec-
tively, Cell Signaling Technology); total and phospho-Ser473 Akt
(9272 and 9271, respectively, Cell Signaling Technology); total
and phospho-Thr172 AMPK (2532 and 2535, respectively, Cell
Signaling Technology; and NBCe1 (11867, Cell Signaling).
STATISTICS
Values are presented as means ± standard error (SE). For group
comparisons, a mixed factor analysis of variance with repeated
measures on the second factor was used. Individual comparisons
were performed using two-tailed Student’s t-test, and a p-value of
<0.05 was considered significant.
RESULTS
CARDIOVASCULAR PERFORMANCE IS NORMAL IN AE3-NULL MICE ON
THE FVB/N BACKGROUND
In a previous study we analyzed the effects of the AE3 null
mutation using mice of a mixed 129Svj and Black Swiss back-
ground and found no significant differences in cardiovascular
performance (Prasad et al., 2008). However, contractile differ-
ences have been shown to exist between mice of different genetic
backgrounds (Kadambi et al., 1999). Of particular relevance, the
inotropic effects of β-adrenergic stimulation are significantly dif-
ferent between wild-type (WT) mice of the 129Svj and Black
Swiss mixed background and the inbred FVB/N background, with
the mixed background mice achieving much greater values for
+dP/dt in response to dobutamine. Therefore, we performed IVP
analysis of WT and AE3-null mice on the inbred FVB/N back-
ground that was used to analyze the effects of AE3 ablation in
the TM180 HCM model (Al Moamen et al., 2011). Although
mean absolute values of −dP/dt for AE3-null mice were some-
what lower than in WT mice, the differences were not significant
and no significant differences in other cardiovascular parame-
ters, including heart rate, mean arterial pressure, and +dP/dt,
were observed betweenWT and AE3-null mice under either basal
conditions or after β-adrenergic stimulation (Figure 1).
POSITIVE FORCE-FREQUENCY RELATIONSHIP IS BLUNTED IN
AE3-NULL MICE
A common feature of heart failure is a reduction in the positive
FFR (Rossman et al., 2004). In our studies of the effects of AE3
ablation in the TM180 HCM model (Al Moamen et al., 2011),
FFR and the ability to pace hearts to higher frequencies appeared
to be more affected in double mutants, although this could have
been a function of the more severe heart failure. To assess FFR
in WT and AE3-null mice, animals were surgically instrumented
and cardiovascular parameters were recorded as hearts were paced
in vivo from baseline to 550 bpm. In an initial set of mice (n = 7
pairs) in which pacing up to 750 bpm was attempted, AE3-null
mice tended to be less able than WT mice to sustain higher
heart rates. Thus, in subsequent experiments, pacing was lim-
ited to 550 bpm, and heart samples were collected for biochemical
studies described in later sections.
Pacing in WT mice led to an increase in +dP/dt, from 8402 ±
296mm Hg/s at 350 bpm to 11700 ± 470mm Hg/s at 550 bpm;
the corresponding increase in mutant mice was from 8112 ± 534
FIGURE 1 | Cardiovascular performance in wild-type and AE3-null
mice. Intraventricular and arterial pressures were measured in
instrumented anesthetized mice using transducers inserted in the left
ventricle and right femoral artery, respectively. Results shown include: (A)
heart rate; (B) mean arterial pressure (MAP); (C) +dP/dt; and (D) −dP/dt
under both basal conditions and upon β-adrenergic stimulation by infusion
of dobutamine via the femoral vein. Values shown are means ± SE, n = 11
for WT, 9 for AE3-null (KO); no significant differences were observed
between WT and KO mice.
at 350 bpm to 10066 ± 588mm Hg/s at 550 bpm (Figure 2A).
Because baseline heart rate for some mice was above 350 or
400 bpm, the significant blunting of rate-dependent inotropy was
also quantified as the difference between +dP/dt at baseline and
550 bpm (+dP/dt). +dP/dt was 1434 ± 210mm Hg/s in
WT mice, whereas in AE3-null mice it was 696 ± 297mm Hg/s
(Figure 2B). Basal heart rates were comparable between WT and
AE3-null hearts (WT: 403 ± 10 bpm; AE3-null: 396 ± 9 bpm,
p = 0.6).
Blood pressure and left ventricular systolic pressure in FVB/N
mice remain at a relatively constant level as heart rate increases
(for example, see mean arterial pressure and corresponding
heart rates in Figure 1) and do not exhibit a significant fre-
quency response. Consistent with this observation, mean arterial
pressures (in mm Hg ± SD) changed very little between base-
line (WT, 79.0 ± 8.1; AE3-null, 72.1 ± 10.2) and 550 bpm
(WT, 84.6 ± 8.1; AE3-null 75.7 ± 11.2). Similarly, left ven-
tricular systolic pressure exhibited essentially no change in
either genotype between baseline (WT, 96.5 ± 11.2; AE3-
null, 88.3 ± 11.9) and 550 bpm (WT, 99.1 ± 10.6; AE3-null,
88.8 ± 12.9).
In some forms of heart failure, a reduction in frequency-
dependent acceleration of relaxation (FDAR), indicative of
impaired relaxation, is observed (Wachter et al., 2009). Although
pacing-induced changes in−dP/dt were blunted in AE3-null mice
(Figure 2C) and the −dP/dt at 550 bpm—baseline (Figure 2D)
was reduced in AE3-null mice (−870 ± 172 and −592 ± 188mm
Hg/s in WT and AE3-null, respectively), the differences were not
significant. Also, tau values (Figure 2E), a more reliable mea-
sure of relaxation (Weiss et al., 1976), were not significantly
different under basal conditions (10.2 ± 0.5 and 11.3 ±
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FIGURE 2 | Force-frequency relationships in wild-type and AE3-null mice.
Pressure measurements were recorded in anesthetized WT and AE3-null (KO)
mice that were instrumented as described in Figure 1, and subjected to
closed-chest atrial pacing from 350 to 550 bpm. Results show: (A) changes in
+dP/dt upon pacing; (B) changes in +dP/dt represented as  +dP/dtmax and
calculated as the difference between values at 550 bpm and baseline heart rate,
which was comparable between genotypes (WT: 403 ± 10bpm; AE3-null: 396
± 9bpm, p = 0.6); (C) changes in −dP/dt upon pacing; (D) changes in −dP/dt
represented as  −dP/dt and calculated as the difference between values at
550 bpm and baseline heart rate; (E) Tau (relaxation time constant) values under
basal and paced conditions; (F) changes in left ventricular end diastolic pressure
(LVEDP) upon pacing. Values shown are means ± SE, n = 19 mice for each
genotype except for dP/dt values at 350 bpm (n = 4 for each genotype) and
400 bpm (n = 9 for each genotype). ∗p < 0.05.
0.6ms in WT and AE3-null, respectively) or when paced at
550 bpm (9.4 ± 0.4 and 10.2 ± 0.5ms in WT and AE3-
null, respectively). Finally, left ventricular end diastolic pres-
sure during pacing was similar in WT and AE3 mutant mice
(Figure 2F).
EXPRESSION OF PROTEINS THAT AFFECT Ca2+-HANDLING IS ALTERED
IN AE3-NULL MICE
Perturbations in Ca2+ handling occur frequently in heart disease,
and could therefore be a contributing factor in an underlying
predisposition to heart failure. Immunoblot analyses using total
cardiac homogenates revealed modest changes in proteins known
to affect Ca2+-handling. Mutant hearts exhibited increased
levels of the NCX1 Na+/Ca2+ exchanger (Figure 3A) and the
NHE1 Na+/H+ exchanger (Figure 3B), which is increased in
cardiac hypertrophy and can affect Ca2+ handling via NCX1-
mediated Na+-loading (Karmazyn et al., 2008). Expression
of the α2 subunit of the L-type Ca2+ channel (LTCC) was
reduced (Figure 3C), and cardiac ryanodine receptor (RYR2)
levels were unaltered (Figure 3D). There was a small but signif-
icant increase in SERCA2 in mutant hearts (Figure 3E; 116 ±
3% of WT levels), which might be expected to improve Ca2+
handling, but levels of total phospholamban (PLN) and PLN
phosphorylated on either Thr17 or Ser16 (Figures 3F–H) were
unaltered.
NBCe1 mRNA AND PROTEIN EXPRESSION IS DOWN-REGULATED IN
AE3-NULL MICE
To address the possibility that loss of AE3 altered expression
of other major HCO−3 transporters in heart, RT-PCR analysis
of total RNA from WT and AE3-null hearts was carried out.
Results showed that mRNA levels of Slc4a4, which encodes the
electrogenic NBCe1 Na+/HCO−3 cotransporter were downregu-
lated in AE3 null hearts (74 ± 3% of WT levels; Figure 4A).
In contrast, no change was observed in expression levels of
Slc4a7, which encodes the electroneutral NBCn1 Na+/HCO−3
cotransporter, and Slc26a6, which codes for PAT1 (Figures 4B,
C). Consistent with these results, immunoblot analysis of total
cardiac homogenates revealed that NBCe1 protein levels, when
normalized to sarcomeric actin, were also reduced in AE3-null
hearts (70 ± 6% of WT levels; Figures 4D, E).
Ca2+ TRANSIENTS ARE NORMAL IN AE3-NULL MYOCYTES
In previous studies, Ca2+ transients were reduced and decay
times were prolonged in isolated ventricular myocytes from
TM180 HCM mice carrying the AE3-null mutation (Al Moamen
et al., 2011), although it seemed likely that this was due to
the greater severity of the disease state in AE3/TM180 double
mutant mice. To assess the effects of AE3 ablation alone on
Ca2+ handling, Ca2+-transients in response to field-stimulation
at 0.5Hz were analyzed in isolated myocytes of WT and AE3-null
Frontiers in Physiology | Membrane Physiology and Membrane Biophysics December 2013 | Volume 4 | Article 399 | 4
Prasad et al. Cardiac effects of AE3 ablation
FIGURE 3 | Expression of proteins that affect Ca2+-handling in wild-type
and AE3-null hearts. Proteins from total homogenates of WT and AE3-null
(KO) hearts were subjected to immunoblot and densitometric analyses; levels
of each protein were normalized to levels of sarcomeric actin (s.actin) in the
same sample. Results show representative immunoblots, with sarcomeric
actin controls, and percent expression levels of: (A) NCX1 Na+/Ca2+
exchanger; (B) NHE1 Na+/H+ exchanger; (C) L-Type Ca2+ channel α2 subunit;
(D) ryanodine receptor (RYR); (E) SERCA2a Ca2+ pump; (F) phospholamban
(PLN); (G) PLN phosphorylated on Thr17 (PT17); and (H) PLN phosphorylated
on Ser16 (PS16). P andM indicate pentameric and monomeric forms of PLN,
respectively. Values shown are mean ± SE, n = at least 4 mice for each
genotype. ∗p < 0.05 vs. WT.
hearts (Figure 5A). Neither the amplitude of the Ca2+-transient
(Figure 5B) nor the time to 50% decay (Figure 5C) was altered,
indicating that Ca2+ release and sequestration were relatively
normal in AE3-null myocytes. However, it should be noted that
during stimulation the AE3-null myocytes exhibited a much
greater tendency to lose their characteristic shape and round up
(see Discussion).
PHOSPHORYLATION OF PLN Thr17 IS NOT ALTERED IN AE3-NULL
HEARTS DURING PACING
A rare mutation in PLN has been implicated in HCM (Landstrom
et al., 2011), and phosphorylation of Thr17 and Ser16 of PLN
has been shown to be reduced in a dog model of HCM (Mishra
et al., 2003). Furthermore, stimulation of Thr17 phosphorylation
is required for a robust FFR in isolated mouse cardiomyocytes
(Zhao et al., 2004), albeit at much lower frequencies than those
occurring in vivo. Immunoblotting showed that phosphoryla-
tion of Thr17 was not significantly different in WT and AE3-
null hearts under basal conditions (Figure 3G) or after in vivo
pacing at 550 bpm (Figure 6A). Similar studies of phosphory-
lation of Ser16 of PLN, which did not differ between WT and
AE3-null mice under basal conditions (Figure 3H), revealed no
differences between the two genotypes during pacing at 550 bpm
(Figure 6B). These results and the modest increase in levels of
SERCA2 (Figure 3E), which is often reduced in heart failure (Kho
et al., 2012), argue against a primary role for an in vivo deficit
in sarcoplasmic reticulum Ca2+ handling in the predisposition of
AE3-null mice to heart failure in the HCMmodel.
PHOSPHORYLATION OF MyBP-C AND TnI IS NOT ALTERED IN
AE3-NULL HEARTS DURING PACING
Mutations in a number of myofibrillar proteins, including TnI
and MyBP-C, have been identified in HCM (Frey et al., 2011;
Marston et al., 2012), and phosphorylation of both TnI and
MyBP-C (Tong et al., 2004; Bilchick et al., 2007; Zhang et al.,
2011) have been shown to affect frequency-dependent responses.
Immunoblot analyses of total cardiac homogenates revealed
that the expression levels of both proteins and the relative
phosphorylation levels of TnI (Ser22/23) and MyBP-C (Ser282)
were not significantly altered in mutant hearts under either
basal conditions (Figures 7A,C) or after pacing to 550 bpm
(Figures 7B,D).
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FIGURE 4 | Expression of HCO−3 transporters in AE3-null hearts. RT-PCR
analysis of cDNA generated from total RNA of WT and AE3-null (KO) hearts
was carried out to determine mRNA levels the Slc4a4 and Slc4a7
Na+/HCO−3 cotransporters and Slc26a6, encoding the anion exchanger
PAT1. When normalized to Gapdh levels, expression of Slc4a4 was
downregulated in AE3-null hearts (A), while Slc4a7 (B) and Sl26a6 (C)
levels showed no change. Total cardiac homogenates of WT and KO hearts
were subjected to immunoblot and densitometric analyses as described in
Figure 3; results show that NBCe1 protein expression, when normalized to
levels of sarcomeric actin (s.actin) was reduced in AE3-null hearts (D,E).
Values shown are mean ± S.E. n = at least 10 mice of each genotype for
RT-PCR analysis and at least 7 mice of each genotype for immunoblot
analysis. ∗p < 0.02 vs. WT.
PHOSPHORYLATION OF Akt IS INCREASED IN AE3-NULL HEARTS
DURING PACING
Besides myofibrillar proteins, mutations in proteins involved in
biomechanical stress sensing and responses have been impli-
cated in both regulation of contractility (Bendig et al., 2006;
Meder et al., 2011) and HCM (Frey et al., 2011). The reduc-
tion in positive FFR indicated that the contractile response to
acute biomechanical stress was deficient in AE3-null hearts. Thus,
it seemed possible that alterations in biomechanical stress sens-
ing and/or responses might be involved in the susceptibility of
AE3-null mice to heart failure in HCM.
AE3 has been localized to t-tubules and to the sarcolemma,
where it appears to be associated with costameres (Alvarez et al.,
2007a). Integrin-linked kinase (ILK), which interacts with β1-
integrin, is a component of a sensor/signaling complex that is
located at the costamere and plays a role in biomechanical stress
sensing and signaling (Meder et al., 2011). Interestingly, the kid-
ney AE1 Cl−/HCO−3 exchanger, a closely related member of the
Slc4a family that is expressed in α-intercalated cells of the collect-
ing duct, has been shown to interact with ILK (Keskanokwong
et al., 2007). The IPP complex initiates mechanosensory signaling
cascades in heart, and phosphorylation of Ser473 of Akt is a key
signaling event in this pathway (Brancaccio et al., 2006; Srivastava
and Yu, 2006). Activation of Akt can contribute to cardiac con-
tractility (Condorelli et al., 2002), but its long-term activation can
also lead to hypertrophy and heart failure (Chaanine and Hajjar,
2011; Sussman et al., 2011), suggesting that it might be involved
in the AE3 phenotype.
To determine whether activation of the Akt pathway was
affected by the loss of AE3, phosphorylation of Akt on Ser473 was
analyzed in ventricle tissue from WT and AE3-null mice under
basal conditions and after in vivo pacing at 550 bpm. Under basal
conditions there was no significant difference between WT and
AE3-null hearts; however, Akt phosphorylation was significantly
greater in hearts from AE3-null mice subjected to in vivo pac-
ing when compared to hearts from corresponding WT controls
(Figure 8; 168 ± 18% of WT levels). This suggests that biome-
chanical stress sensing and signaling via AKT responds more
strongly in AE3-null hearts than in WT hearts.
PHOSPHORYLATION OF AMPK IS DECREASED IN AE3-NULL HEARTS
DURING PACING
There is evidence that activated Akt has a negative regulatory
effect on AMP-activated protein kinase (AMPK) (Kovacic et al.,
2003; Soltys et al., 2006). AMPK serves as a master regulator of
cellular energy pathways (Zaha and Young, 2012), and mutations
in the PRKAG2 gene, encoding a regulatory subunit of AMPK,
are known to cause HCM (Blair et al., 2001; Arad et al., 2002;
Banerjee et al., 2010). This raises the possibility that perturbations
of AMPK activity, secondary to enhanced Akt activation, might
contribute to the heart failure phenotype in the AE3/TM180
HCM model (Al Moamen et al., 2011). To test this hypothesis
we analyzed phosphorylation of AMPK on Thr172, which causes
a sharp increase in enzyme activity (Zaha and Young, 2012). As
observed for Akt phosphorylation, no differences in phosphoryla-
tion were observed under basal conditions (Figure 9A); however,
AMPK phosphorylation was reduced in AE3-null hearts rela-
tive to WT controls when paced in vivo at 550 bpm (Figure 9B),
suggesting that impairments of energy metabolism may also
contribute to the AE3-null phenotype.
DISCUSSION
Previous studies of the AE3-null mouse on an otherwise wild-
type background revealed no evidence of a deficit in cardiovascu-
lar performance (Prasad et al., 2008). However, when combined
with the α-tropomyosin Glu180Gly HCM mutation, the loss of
AE3 led to more rapid decompensation and heart failure (Al
Moamen et al., 2011). Those findings indicated that ablation
of AE3 makes the heart more susceptible to heart failure in
HCM, suggesting that AE3-mediated Cl−/HCO−3 exchange plays
an important role in cardiac function. In the current study, we
analyzed the effects of AE3 ablation on regulatory mechanisms
known to contribute to normal contractile function in heart,
including some that are affected in HCM. The data suggest that
loss of AE3-mediated Cl−/HCO−3 exchange perturbs the ability
of the heart to respond effectively to acute biomechanical stress.
IVP analyses of basal contractility and β-adrenergic responses
was carried out using mice on an inbred FVB/N background.
Although similar studies were carried out previously using WT
and AE3-null mice of the 129Svj and Black Swiss mixed back-
ground (Prasad et al., 2008), there is evidence that the genetic
background can have pronounced effects on inotropic responses
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FIGURE 5 | Analysis of Ca2+-transients in cardiac myocytes from
wild-type and AE3-null mice. Ca2+-transients were calculated as
340/380 ratios from fluorescence measurements in isolated myocytes
from WT and AE3-null (KO) mice loaded with Fura-2. Results show: (A)
representative tracings; (B) Ca2+-transient amplitudes; and (C) time to
50% recovery of Ca2+-transients in response to electrical field-stimulation
at 0.5Hz. Values are means ± SE, n = 3 mice per genotype (at least 36
cells/genotype).
FIGURE 6 | Phosphorylation of phospholamban in wild-type and
AE3-null hearts subjected to atrial pacing in vivo. WT and AE3-null
(KO) mice were anesthetized, instrumented, and subjected to in vivo
pacing as described in Figure 2. Ventricular tissue was harvested during
pacing at 550 bpm, and immunoblot and densitometric analyses of
homogenates were carried out to determine levels of (A) PLN
phosphorylated on Thr17 (PT17) and (B) PLN phosphorylated on Ser16
(PS16). Results show representative immunoblot and percent relative
levels of phosphorylated PLN (normalized to total PLN levels). Note that
PLN phosphorylation did not differ between the two genotypes under
basal conditions (Figures 3G, H). Values shown are means ± SE, n = 8
for each genotype.
FIGURE 7 | Phosphorylation of cardiac troponin I (TnI) and myosin
binding protein-C (MyBP-C) in wild-type and AE3-null hearts subjected
to atrial pacing. WT and AE3-null (KO) mice were anesthetized,
instrumented, and subjected to pacing as described in Figure 2. Ventricular
tissue was harvested under basal conditions in instrumented controls or
during pacing at 550 bpm. Immunoblot and densitometric analyses of
homogenates were carried out to determine levels of: (A) total TnI and
phosphorylated TnI (Ser22/23) under basal conditions; (B) total TnI and
phosphorylated TnI (Ser22/23) during pacing; (C) total MyBP-C and
phosphorylated MyBP-C (Ser282) under basal conditions; and (D) total
MyBP-C and phosphorylated MyBP-C (Ser282) during pacing at 550 bpm.
Results show representative immunoblots, and percent relative levels
(normalized to total TnI or MyBP-C levels) of phosphorylated TnI or MyBP-C.
The two genotypes exhibited no differences in either total TnI or total
MyBP-C. Values shown are means ± SE, n = 4 mice for each genotype and
pacing condition.
in mice (Kadambi et al., 1999). The reasons underlying these
background-specific differences are unclear, but may involve vari-
ations in Ca2+-handling and the expression, localization, or
activation of key signaling molecules. Nevertheless, cardiovascu-
lar performance under basal conditions and the chronotropic,
inotropic, and lusitropic effects of β-adrenergic stimulation were
largely normal in AE3-null mice of either background (Prasad
et al., 2008; current study).
Frequency-dependent augmentation of contractility is a key
intrinsic regulatory mechanism in heart, and in a healthy
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FIGURE 8 | Phosphorylation of Akt in wild-type and AE3-null hearts
subjected to atrial pacing in vivo. WT and AE3-null (KO) mice were
anesthetized, instrumented, and subjected to pacing as described in
Figure 2. Ventricular tissue was harvested under basal conditions in
instrumented controls or during pacing at 550 bpm. Immunoblot and
densitometric analyses of homogenates were carried out to determine
levels of: (A) total Akt and phosphorylated Akt (Ser473) under basal
conditions; and (B) total Akt and phosphorylated Akt (Ser473) during pacing
at 550 bpm. Results show representative immunoblot and percent relative
levels (normalized to total Akt levels) of phosphorylated Akt. Values shown
are means ± SE, n = at least 10 for each genotype and pacing condition.
∗p < 0.05 vs. WT.
FIGURE 9 | Phosphorylation of AMPK in wild-type and AE3-null hearts
subjected to atrial pacing in vivo. WT and AE3-null (KO) mice were
anesthetized, instrumented, and subjected to pacing as described in
Figure 2. Ventricular tissue was harvested under basal conditions in
instrumented controls or during pacing at 550 bpm. Immunoblot and
densitometric analyses of homogenates were carried out to determine
levels of: (A) total AMPK and phosphorylated AMPK (Thr172) under basal
conditions; and (B) total AMPK and phosphorylated AMPK (Thr172) during
pacing at 550 bpm. Results show representative immunoblot and percent
relative levels (normalized to total AMPK levels) of phosphorylated AMPK.
Values shown are means ± SE, n = at least 8 for each genotype and pacing
condition. ∗p < 0.05 vs. WT.
myocardium the relationship between increased heart rate and
contractility is positive (Endoh, 2004). Although less robust than
in larger mammals such as humans, FFR in mice seems to
be qualitatively similar to FFR in larger mammals (Palakodeti
et al., 1997). Because frequency-dependent responses are often
impaired in heart failure (Rossman et al., 2004), cardiac per-
formance was analyzed in vivo under basal conditions and after
pacing to 550 bpm. Relative to WT mice, which developed a
well-defined positive FFR, with increases in +dP/dt consistent
with previous studies using atrial pacing in closed-chest mice
(D’Angelo et al., 1997), the positive FFR was blunted in AE3-
null mice. The effects in AE3-null mice were variable, with some
AE3-null mice exhibiting a robust FFR. Also, as noted above,
contractile dysfunction was not apparent during β-adrenergic
stimulation. Nevertheless, the observed blunting of frequency-
dependent inotropy provides the first direct evidence of contrac-
tile dysfunction due to the loss of AE3 alone.
The mean values for pacing-induced differences in −dP/dt,
although not statistically significant, were reduced in AE3-null
mice, suggesting the possibility of diastolic dysfunction. For
example, FDAR is impaired in humans exhibiting heart failure
with normal ejection fraction (Wachter et al., 2009). However,
tau values and LVEDP, which are more reliable measures of
relaxation and diastolic dysfunction (Weiss et al., 1976), were
both significantly elevated in those patients, whereas in AE3-
null mice these parameters were not significantly different from
those in WT controls. Furthermore, phosphorylation of PLN
and TnI, both of which affect relaxation (Wolska et al., 2002),
were not changed in the pacing experiments. Thus, impairment
of frequency-dependent effects in AE3-null mice appears to be
limited to contractility.
Ca2+ is a major regulator of cardiac function, and altered
expression of Ca2+-handling proteins has been correlated with
impaired contractility (Periasamy et al., 1999; Pieske et al., 1999;
Seidler et al., 2007). Although AE3-null hearts exhibited nor-
mal basal contractility and β-adrenergic responses, immunoblot-
ting revealed increased expression of SERCA2 and NCX1, which
together account for most of the Ca2+-clearance from the cytosol
during diastole, and reduced expression of LTCC, which mediates
Ca2+-influx on a beat-to-beat basis. Despite these changes, Ca2+-
handling was unaltered in AE3-null myocytes, as indicated by no
differences in peak Ca2+ or in the rate of decay of the Ca2+ tran-
sient in electrically stimulated myocytes in vitro. The observed
changes in expression of Ca2+-handling proteins and the Ca2+
imaging experiments in isolated myocytes do not support the
hypothesis that perturbations of Ca2+-handling are the primary
cause for the reduction in rate-dependent inotropy. However, as
discussed below, these data do not rule out the possibility that
impairment of Ca2+ handling in vivo contributes to susceptibility
to HCM or to the blunting of the positive FFR in AE3-null mice.
A positive FFR has been observed in isolated mouse myocytes,
in a range of frequencies (up to 300 bpm) that are below those
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occurring in vivo, and appeared to be dependent on increased
phosphorylation of PLN on Thr17 (Zhao et al., 2004), which
increases SERCA2 activity. However, phosphorylation of Thr17
and Ser16 was similar in hearts of AE3-null and WT mice dur-
ing pacing in vivo, indicating that reduced phosphorylation of
PLN, which would limit SERCA2 activity, does not contribute to
the differences in FFR between the two genotypes. Furthermore,
a reduction in SERCA2 expression has been shown to cause
blunting of the positive FFR in mice (Huke et al., 2003). Thus, the
increased expression of SERCA2 observed in hearts of AE3-null
mice would be expected to improve, rather than impair, con-
tractility and the positive FFR. Similarly, the increase in NCX1
and NHE1 levels could contribute to increased Ca2+-loading via
reverse mode activity of the Na+/Ca2+ exchanger, thereby leading
to improved contractility. In fact, increased NCX1 expression has
been associated with better preservation of both systolic (LaRocca
et al., 2012) and diastolic (Hasenfuss et al., 1999) function in
heart failure. The likely effects of decreased LTCC expression on
frequency-dependent inotropy is difficult to predict. Either phar-
macologic stimulation or inhibition of the LTCC in muscle strips
of human failing heart caused an increase in the positive FFR,
although basal contractility was reduced by inhibition of channel
activity (Reuter et al., 1999). Overall, our results suggest that alter-
ations in Ca2+-handling or expression of Ca2+-handling proteins
resulting from the loss of AE3, at least as it relates to direct mod-
ulation of the contractile apparatus, are unlikely to contribute to
the reduction in rate-dependent inotropy or to the more rapid
decompensation and heart failure observed in the HCM model
(Al Moamen et al., 2011).
NBCe1 was shown previously to be upregulated in the retina
of AE3-null mice (Alvarez et al., 2007b), an effect opposite to the
reduction in NBCe1 expression seen in AE3-null hearts. NBCe1
canmediate Na:HCO−3 cotransport with a stoichiometry of either
1:2 or 1:3 (Gross and Kurtz, 2002). In heart it has a ratio of 1:2 and
mediates inward cotransport (Garciarena et al., 2013). However,
in retina the Na:HCO−3 ratio is 1:3 (Newman and Astion, 1991),
as in kidney, which would allow outward transport of Na+ and
HCO−3 . In fact, Alvarez et al. (2007b) suggested that both AE3 and
NBCe1 in the end feet of Muller cells mediate outward transport
of HCO−3 . Thus, an increase in NBCe1 expression in the retina
would be expected to provide some compensation for the loss
of HCO−3 extrusion via AE3. In contrast, loss of AE3 in heart
would eliminate a major HCO−3 extrusion activity, so a reduc-
tion in HCO−3 -uptake via NBCe1 would be expected to provide
some degree of compensation with respect to intracellular HCO−3 .
Thus, the reduction in NBCe1 expressionmay compensate in part
for perturbations of intracellular pH (pHi) that occur in response
to loss of AE3; however, it could also affect Na+-loading.
NBCe1 andNHE1 have been identified asmajor acid extrusion
mechanisms in cardiac myocytes (Garciarena et al., 2013). Both
transporters mediate Na+-uptake, which in turn can increase
contractility by Ca2+-loading via reverse mode activity of the
Na+/Ca2+ exchanger. With expression in both t-tubules and
sarcolemma (Garciarena et al., 2013), and relatively high expres-
sion in heart (Prasad et al., 2013), NBCe1 may be capable of
Na+-loading in a manner that could affect Ca2+-loading. It has
been shown that an increase in the frequency of contraction
of papillary muscles in CO2/HCO
−
3 buffered media leads to an
increase in pHi that can be blocked by a Na+/HCO−3 cotransport
inhibitor (Camilión de Hurtado et al., 1996). The authors con-
cluded that an electrogenic Na+/HCO−3 cotransporter, now
known to be NBCe1, is strongly activated by depolarization
during each action potential and that Na+/HCO−3 cotransport
activity increased as heart rate increased. Thus, it is possible that
pacing to higher heart rates in vivo leads to a transient increase
in both pHi and Na+. If this were the case, then AE3-mediated
HCO−3 extrusion would tend to maintain a strong driving force
for NBCe1 activity by reducing intracellular HCO−3 and, because
it is expressed in t-tubules (Alvarez et al., 2007a), AE3 would
replenish HCO−3 concentrations in the lumen of the t-tubule.
Thus, it is possible that the loss of AE3 and the reduction in
NBCe1 expression could lead to a reduction in Na+-loading at
elevated heart rates, which could affect Ca2+-loading, contractil-
ity, and the FFR.
An additional effect of changes in AE3 and NBCe1 activity
might be alterations in the activity of L-type Ca2+ channels,
which would also affect Ca2+-loading. It has been shown that
a reduction in pHi increases L-type Ca2+ currents, whereas
a decrease in extracellular pH (pHo) decreases Ca2+ currents
(Saegusa et al., 2011). By extruding HCO−3 across the sarcolemma
or t-tubular membranes, AE3 would be expected to reduce pHi
and increase pHo in its immediate vicinity, which would be pre-
dicted to increase Ca2+ currents, whereas NBCe1 activity would
be expected to have the opposite effect. Also, it has been suggested
that NBCe1 activity, because of its anionic current, reduces the
duration of the action potential (De Giusti et al., 2011). Thus,
the loss of AE3 could lead to a reduction in L-type Ca2+ cur-
rents, with a consequent reduction in contractility. A reduction
in NBCe1 activity, by reducing the magnitude of these pH pertur-
bations and increasing action potential duration, might provide
some compensation. The remarkably strong co-localization of
NBCe1 and L-type Ca2+ channels (Garciarena et al., 2013) sup-
ports the possibility that NBCe1 regulates Ca2+ channel activity.
Additional studies will be needed to assess these possibilities.
Along with Ca2+-handling, alterations in myofibrillar Ca2+-
responsiveness are known to regulate contractility (Allen and
Kentish, 1985; Kentish, 1986; Ruegg, 1987), and phosphoryla-
tion of myofibrillar proteins such as MyBP-C and TnI plays a
key role in determining Ca2+-sensitivity, and therefore contractil-
ity (Kentish et al., 2001; Solaro, 2002; Barefield and Sadayappan,
2010). In addition, mutations in both TnI and MyBP-C are
known causes of HCM (Frey et al., 2011; Marston et al., 2012).
However, we observed no alterations in the expression or phos-
phorylation of MyBP-C or TnI, suggesting that changes involving
these proteins do not contribute to the blunted FFR or to the
increased susceptibility to HCM and decompensation in heart
failure observed in AE3-null mice.
An observation made during Ca2+ imaging analysis of isolated
myocytes may provide a clue to a deficiency caused by the loss
of AE3. Isolated AE3-null myocytes stimulated at relatively low
frequencies had a greater tendency than WT myocytes to round
up. The basis for this structural change has not been investigated
further, but rounding up of ventricular myocytes in culture is
associated with breakdown of the cytoskeleton or dissociation of
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costameres from Z-lines of the myocyte (Imanaka-Yoshida et al.,
1996; Weikert et al., 2003). The presence of AE3 at costameres
(Alvarez et al., 2007a) is consistent with a role in cytoskeletal
integrity, a feature that it may share with other anion exchang-
ers of the Slc4a family. AE1, the Band 3 Cl−/HCO−3 exchanger,
has a well-known role in maintaining cytoskeletal integrity of
the erythrocyte (Peters et al., 1996; Southgate et al., 1996)
and, in osteoclasts, AE2 activity regulates the reorganization
of actin superstructures and disassembly of podosomes (Coury
et al., 2013). Podosomes and costameres are similar in that they
are integrin-containing structures that interact with both the
cytoskeleton and extracellular matrix and serve as major cen-
ters of mechanosensing and signaling (Samarel, 2005; Schachtner
et al., 2013). For AE2, it has been shown that its Cl−/HCO−3
exchange activity is necessary for normal podosome function;
however, the N-terminal cytoplasmic domain that interacts with
cytoskeletal components is not essential (Coury et al., 2013), sug-
gesting that direct physical interactions with the cytoskeleton are
not necessary.
The ability to sense and respond to changes in mechanical
stress is a critical regulatory mechanism in heart (Hoshijima,
2006; Heineke and Molkentin, 2006). Costameres form struc-
tural links between Z-discs and the extracellular matrix and serve
as integrative nodal points in the mechanosensory machinery
(Samarel, 2005). The IPP complex, a sub-sarcolemmal multi-
protein complex that includes integrins and ILK, is critical for
mechanosensing at costameres (Brancaccio et al., 2006; Srivastava
and Yu, 2006), and Akt has been identified as a key player in
mechanosensory signaling via this complex (Meder et al., 2011).
We therefore explored the possibility that Akt activity, as evi-
denced by phosphorylation of Akt on Ser473, was affected in
mutant hearts. Although Akt phosphorylation was the same in
mutant and WT hearts under basal conditions, p-Akt levels were
significantly higher in AE3-null hearts when subjected to in vivo
pacing, indicating that this mechanosensitive signaling pathway
was activated to a greater degree in AE3-null hearts than in WT
hearts. It should be noted that the increase in p-Akt levels dur-
ing pacing would not be expected to contribute to the blunting of
rate-dependent inotropy because increased Akt activity has been
shown to enhance contractility (Condorelli et al., 2002; Cittadini
et al., 2006; Sussman et al., 2011). Rather, it is likely that the
enhanced Akt phosphorylation is a compensatory mechanism
that is required to maintain a more normal FFR in AE3-null
hearts.
Given its critical signaling function in heart, with effects
on contractility, muscle mass, myocyte survival, and energy
metabolism (Sussman et al., 2011), the elevation of Akt activity,
if it were chronic, would be likely to have major consequences
in mutant hearts (Chaanine and Hajjar, 2011). The average basal
heart rate in the anesthetized mice used in this study (∼400 bpm)
is well below the ∼550–600 bpm we have measured by telemetry
in awakeWTmice (Bradford et al., 2010); however, the electrically
paced heart rate of 550 bpm, where activated Akt was observed, is
within the normal range for awake mice and much higher heart
rates can be achieved when mice are active. Thus, it is possible
that Akt is chronically activated in awake AE3-null mice. The
mildly increased expression of SERCA2 and NCX1 could be due
to chronically activated Akt as transgenic overexpression of Akt
caused a sharp increase in the levels of SERCA2 (Kim et al., 2003;
Cittadini et al., 2006) and NCX1 (Formisano et al., 2008).
The mechanisms by which loss of AE3 might lead to increased
biomechanical stress or affect sensing and responses to such stress
are unclear. We suggested previously that in cardiac myocytes,
AE3 may act in concert with a Na+-loading acid extruder, reg-
ulating sub-sarcolemmal [Na+] and thereby modulating [Ca2+]
in localized microdomains (Prasad et al., 2008) rather than in
the bulk cytosol where it would be expected to affect contrac-
tility directly. The similar localization of AE3 (Alvarez et al.,
2007a) and NBCe1 (Garciarena et al., 2013) and the down-
regulation of NBCe1 in AE3-null mice suggest that AE3 might
exhibit some degree of functional coupling with NBCe1. Given
the evidence that spatially compartmentalized Ca2+-signals reg-
ulate mechanical stress-responsive signaling (Judice et al., 2009)
one can speculate that the loss of AE3 might impact the role of
Ca2+ in responses to mechanical stress. An alternative possibil-
ity is that loss of AE3 may impair responses to biomechanical
stress by affecting subsarcolemmal or cytosolic pHi, HCO
−
3 , or
Cl−concentrations. For example, F-actin rearrangements that are
dependent on cofilin 2 and interactions with muscle LIM pro-
tein (MLP or Csrp3) are strongly affected by pHi (Papalouka
et al., 2009), which would likely be more alkaline in subsarcolem-
mal domains following loss of AE3. HCO−3 has been shown to
cause a sharp increase in contractility in isolated hearts, with
no increase in systolic Ca2+, indicating a critical role for HCO−3
homeostasis (Fülöp et al., 2003). Regarding possible effects due to
alterations of cellular Cl− homeostasis, when the AE3 knockout
was crossed with an NKCC1 Na+-K+-2Cl− cotransporter knock-
out, the double mutant exhibited impaired contractility; however,
it appeared likely that this was due to impaired Ca2+ loading
as NCX1-mediated Ca2+ extrusion was increased (Prasad et al.,
2008). Additional studies will be needed to address the molecu-
lar mechanisms by which loss of AE3 affects biomechanical stress
specifically and cardiac function in general.
The data clearly show that Akt signaling is enhanced in AE3-
null hearts during pacing. This would be expected to improve
the heart’s response to biomechanical stress; however, if Akt were
chronically activated, as seems likely given the heart rates that
occur naturally in awake mice, it could also have detrimental
effects (Chaanine and Hajjar, 2011; Sussman et al., 2011). One
such effect is impaired AMPK signaling (Kovacic et al., 2003;
Soltys et al., 2006), which has been linked to genetic HCM
(Blair et al., 2001; Arad et al., 2002; Banerjee et al., 2010).
Phosphorylation of AMPK on Thr172 was the same in AE3-
null and WT hearts of anesthetized mice under basal condi-
tions, but when paced to 550 bpm, phosphorylation in AE3-null
hearts was reduced, consistent with the possibility that enhanced
AKT signaling causes a reduction in AMPK signaling. Reduced
AMPK signaling would be expected to have a negative impact
on metabolism (Dyck and Lopaschuk, 2006; Beauloye et al.,
2011; Zaha and Young, 2012), which in turn could be part of
the mechanism by which AE3-deficiency leads to more rapid
decompensation in heart failure (Al Moamen et al., 2011).
In summary, our results show that the loss of AE3-mediated
Cl−/HCO−3 exchange leads to an impaired FFR, which is a clear
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physiological correlate of the predisposition to heart failure in the
TM180 model of HCM (Al Moamen et al., 2011). The results of
immunoblot analyses of proteins involved in Ca2+ transport and
Ca2+ imaging of isolated myocytes argue against the hypothe-
sis that primary perturbations of Ca2+ handling are responsible
for the physiological deficit, although it is possible that modula-
tory effects of AE3 and NBCe1 activities on Ca2+ channels could
perturb Ca2+ handling at the high frequencies occurring in vivo.
There were no differences in the levels of total or phosphory-
lated MyBP-C and TnI, making it unlikely that altered activities
or Ca2+ sensitivity of these myofibrillar proteins contribute to
the deficit. The most striking change was an increase in phos-
phorylation of Akt and a decrease in phosphorylation of AMPK
during pacing at elevated heart rates. AE3 has been localized to
both sarcolemmal and intracellular membranes, and on the sar-
colemma it appears to be concentrated at costameres (Alvarez
et al., 2007a). Because Akt is known to participate in biomechan-
ical stress signaling originating at costameres (Brancaccio et al.,
2006; Srivastava and Yu, 2006), its increased activation suggests
that hearts of AE3-null mice are more sensitive to acute biome-
chanical stress than hearts of WT mice when subjected to in vivo
pacing. The mechanisms by which loss of AE3 leads to a defi-
cient response to biomechanical stress and the downstream events
that lead to decompensation in heart failure, possibly including
impaired AMPK activation, will be investigated in future studies.
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